Related Experiment Videos
Endoscopic stenting for biliary and pancreatic malignancies
Guido Costamagna1, Monica Pandolfi
1Digestive Endoscopy Unit, Department Of Surgery, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy. gcostamagna@rm.unicatt.it
Journal of Clinical Gastroenterology
|December 18, 2003
Summary
Endoscopic therapy offers a safe and effective palliative option for inoperable pancreatobiliary cancers. Stent choice (plastic vs. metallic) depends on patient prognosis, balancing patency and cost for optimal pain relief.
Area of Science:
- Gastroenterology
- Oncology
- Interventional Endoscopy
Background:
- Endoscopic treatment is the preferred palliative approach for unresectable pancreatobiliary malignancies.
- Key endoscopic tools include biliary and pancreatic stents to manage neoplastic strictures and obstructive pain.
Purpose of the Study:
- To review the role and efficacy of endoscopic interventions in managing pancreatobiliary malignancies.
- To discuss stent options, patency issues, and patient selection criteria for endoscopic palliation.
Main Methods:
- Review of current endoscopic techniques and stent technologies for pancreatobiliary cancers.
- Analysis of stent patency, complications, and cost-effectiveness.
Main Results:
- Plastic stents offer temporary palliation but have limited long-term patency (3-4 months).
- Metallic stents provide longer patency but are costly and prone to tumor ingrowth/overgrowth.
- Pancreatic duct decompression via stenting can effectively relieve obstructive pain.
Conclusions:
- Endoscopic palliation is safe and effective for pancreatobiliary malignancies.
- Optimal patient management requires a multidisciplinary team at referral centers with specialized endoscopic expertise.